Spots Global Cancer Trial Database for Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
Official Title: Phase I-II Clinical and Pharmacokinetic Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
Study ID: NCT00374660
Conditions
Study Description
Brief Summary: The purpose of this study is to determine the maximum tolerated dose (MTD) and to investigate the efficacy, safety and pharmacokinetics of irofulven combined with oxaliplatin in patients with advanced solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Bordeaux, , France
, Clichy, , France
, Lyon, , France
, Nice, , France
, Paris, , France
, Poitiers, , France
, Saint Cloud, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
